Ronald Angles, DO
Gastroenterology · Cape Girardeau, MONPI 1245284918
Payments from drug & device makers
Across 41 payments — averaging $57.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Steris Corporation$241
- Phathom Pharmaceuticals, Inc.$122
- Conmed Corporation$108
- Pfizer$91
- Cook Medical LLC$87
- plus $348 from 7 others
What the payments were for
- Food & beverage$2,356100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 14 | $1,361 |
| Steris Corporation | 1 | $241 |
| Phathom Pharmaceuticals, Inc. | 1 | $122 |
| Conmed Corporation | 1 | $108 |
| Pfizer | 6 | $91 |
| Cook Medical LLC | 1 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $77 |
| Covidien LP | 1 | $75 |
| Micro-tech Endoscopy USA, Inc. | 1 | $61 |
| Ironwood Pharmaceuticals, Inc | 4 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $43 |
| Daiichi Sankyo Inc. | 1 | $23 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRUFREEZE$241
- EXALT$219
- EXALT Model D$195
- GENERAL - THERAPIES$134
- VOQUEZNA$122
- RESOLUTION CLIP$115
- CONMED HEMOSTASIS$108
- WALLFLEX$101
- ORISE$100
How this compares
$2,356 in reported general payments places this provider in the 50th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 75 | $1,345 |
| Pantoprazole Sodium | 109 | $662 |
| Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg | 35 | $407 |
| Sucralfate | 11 | $304 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 21 | $266 |
| Dicyclomine Hcl | 15 | $185 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $179 |
| Omeprazole | 21 | $153 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Cape Girardeau
- Bradley FreilichKansas City$4.5M
- Parakkal DeepakSaint Louis$2M
- Steven FernSullivan$1.4M
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$920K
- Kevin KorenblatSaint Louis$857K
- Christopher BartalosLees Summit$815K
- Bradley AndersonColumbia$776K
- Brent Neuschwander-TetriSaint Louis$729K
- David AlpersSaint Louis$616K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.